DTM Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
DT Midstream looks like a good buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock is in a clear uptrend, analysts have broadly raised price targets, and the latest commentary points to durable EBITDA growth, a strong contracted footprint, and a growing project backlog. With no recent negative news, no notable insider or hedge fund selling, and no politician trading activity, the setup is constructive. Since you are not looking to wait for a perfect entry, buying now is reasonable.
DTM is technically bullish. Price is above the SMA 5, SMA 20, and SMA 200, confirming a strong trend structure. The MACD histogram is positive and expanding, which supports continued momentum. RSI_6 is 74.948, indicating the stock is running hot but still aligned with strong trend strength rather than a breakdown signal. Price closed at 148.08, just below resistance at 149.299, with pivot support at 145.867. Overall, the chart favors trend continuation and a constructive long-term entry rather than weakness.
["Multiple analysts raised price targets in early May, showing improving Street expectations.", "Raymond James highlighted a highly contracted footprint and growing project backlog.", "Jefferies said the Q1 update was very positive on MIST commercialization and expansion opportunities.", "DT Midstream continues to benefit from long-term natural gas infrastructure demand.", "No recent negative news in the past week.", "No significant insider selling, hedge fund selling, or congress trading activity reported."]
["Goldman Sachs still maintains a Sell rating despite raising its target, showing not all analysts are bullish.", "The stock has already moved near highs, so upside may be more gradual from here.", "RSI is elevated, suggesting momentum is strong but the stock is no longer cheap.", "No fresh financial snapshot was available in the dataset, limiting confirmation of recent quarterly growth."]
The latest quarter is Q1 2026, based on analyst references to the Q1 report. Jefferies described it as a slight beat, and commentary indicates the quarter was positive for commercialization and backlog visibility. However, a full financial snapshot was not available, so revenue and earnings growth rates cannot be directly verified here. The qualitative takeaway is that latest-quarter execution appears solid, with project backlog and expansion progress supporting long-term growth.
Analyst sentiment has improved over the last month. Morgan Stanley raised its target to $170 while keeping Equal Weight, Mizuho raised to $153 with Neutral, Citi raised to $169 with Buy, Jefferies raised to $166 with Buy, Barclays nudged to $143 with Equal Weight, and Raymond James lifted to $158 with Outperform. The main bull case is durable contracted earnings growth, backlog conversion, and project execution. The main bear case is valuation sensitivity and the fact that some firms still remain Neutral or Sell, including Goldman Sachs at Sell. Overall, Wall Street is constructive but mixed, with more price-target hikes than downgrades.
